These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 11064378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
    Groll AH, Mickiene D, Petraitiene R, Petraitis V, Lyman CA, Bacher JS, Piscitelli SC, Walsh TJ.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2845-55. PubMed ID: 11557479
    [Abstract] [Full Text] [Related]

  • 6. LY303366 exhibits rapid and potent fungicidal activity in flow cytometric assays of yeast viability.
    Green LJ, Marder P, Mann LL, Chio LC, Current WL.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):830-5. PubMed ID: 10103187
    [Abstract] [Full Text] [Related]

  • 7. Toxicity of LY303366, an echinocandin antifungal, in mice pretreated with glucocorticoids.
    Clemons KV, Sobel RA, Stevens DA.
    Antimicrob Agents Chemother; 2000 Feb; 44(2):378-81. PubMed ID: 10639365
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.
    Paulson SK, Vaughn MB, Jessen SM, Lawal Y, Gresk CJ, Yan B, Maziasz TJ, Cook CS, Karim A.
    J Pharmacol Exp Ther; 2001 May; 297(2):638-45. PubMed ID: 11303053
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
    Cundy KC, Sue IL, Visor GC, Marshburn J, Nakamura C, Lee WA, Shaw JP.
    J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
    [Abstract] [Full Text] [Related]

  • 13. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
    Wu Y, Loper A, Landis E, Hettrick L, Novak L, Lynn K, Chen C, Thompson K, Higgins R, Batra U, Shelukar S, Kwei G, Storey D.
    Int J Pharm; 2004 Nov 05; 285(1-2):135-46. PubMed ID: 15488686
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.
    Solymosi T, Ötvös Z, Angi R, Ordasi B, Jordán T, Semsey S, Molnár L, Ránky S, Filipcsei G, Heltovics G, Glavinas H.
    Int J Pharm; 2017 Oct 30; 532(1):427-434. PubMed ID: 28919099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.
    Courtney R, Wexler D, Radwanski E, Lim J, Laughlin M.
    Br J Clin Pharmacol; 2004 Feb 30; 57(2):218-22. PubMed ID: 14748822
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.